Electrophysiology market to reach USD 15.1B by 2028

Electrophysiology market in terms of revenue was estimated to be worth $8.2 billion in 2023 and is poised to reach $15.1 billion by 2028, growing at a CAGR of 13.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key market players in developing regions, are driving the growth of the electrophysiology market. This amalgamation of drivers has engendered substantial market growth. Continued technological advancements, heightened emphasis on non-invasive cancer interventions, and a supportive healthcare ecosystem are anticipated to sustain this upward trajectory.

The electrophysiology market by product is segmented into Electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, electrophysiology access devices, and other devices. The electrophysiology laboratory devices accounted for the largest segment in 2022.

Based on the product the electrophysiology laboratory devices hold the largest segment in 2022. Electrophysiology laboratory instruments are critical in the identification and treatment of cardiac arrhythmias. These tools are used to examine the heart’s electrical activity, spot anomalies, and direct procedures like catheter ablation.

By indication Atrial Flutter segment holds the largest share in 2022
The electrophysiology market by indication is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia, wolff-parkinson- white syndrome, and other indications. Atrial flutter is a reasonably frequent cardiac arrhythmia, and its prevalence has been growing, particularly among the elderly. Consequently, there is an increasing need for atrial flutter diagnosis and treatment-related electrophysiological techniques and technologies.

North America to account for a significant market share in the Electrophysiology market in 2022
In 2022, the North America region is expected to register significant growth in the market during the forecast period. North America comprises the US and Canada. North America is a center for medical technology innovation and research. New and cutting-edge electrophysiological technologies are frequently adopted early in the region, which supports market expansion. The United States, in particular, has one of the highest healthcare spending rates in the world. High healthcare spending encourages the employment of cutting-edge medical technologies, such as those utilized in electrophysiology operations.

Key market players of electrophysiology industry:
As of 2022, prominent players in the electrophysiology market are Abbott Laboratories (US), Koninklijke Philips N.V.(Netherlands), Medtronic plc (Dublin)., Microport Scientific Corporation (China), Johnson & Johnson Services, Inc.(US), among others. MarketsandMarkets™